Head of Computational Precision Medicine
United States of America
"Lovisa Afzelius, PhD, is Head of Computational Precision Medicine for the Inflammation & Immunology Research Unit. The goal of the Computational Precision Medicine group is to leverage clinical biomarker information to enable data driven decision making related to target validation, patient stratification, indication expansion and combination rationale. In addition, the Inflammation & immunology research unit aims to provide disease relevant baseline data to project teams across our major disease areas which include Rheumatoid Arthritis, Inflammatory Bowel Disease, Nonalcoholic Steatohepatitis (NASH), and Dermatology. “Data” is primarily well annotated patient -omics data generated from observational cohorts and internal clinical trials but ranges from single cell RNASeq data for a couple of patients to real world data such as electronic medical records (EMR) and claims data for millions of patients. Dr. Afzelius received her PhD from Uppsala University, Sweden within the Department of Organic Pharmaceutical Chemistry. She obtained her Executive MBA from MIT Sloan School of Management."
Her research interests include fields like Inflammation & immunology research.